| Primary |
| Hypertension |
60.0% |
| Essential Hypertension |
40.0% |
|
| Vomiting |
66.7% |
| Palpitations |
33.3% |
|
| Secondary |
| Hypertension |
66.7% |
| Atrial Fibrillation |
16.7% |
| Gastrooesophageal Reflux Disease |
16.7% |
|
| Drug Hypersensitivity |
20.0% |
| Headache |
20.0% |
| Renin Decreased |
20.0% |
| Thrombophlebitis Superficial |
20.0% |
| Vitreous Floaters |
20.0% |
|
| Concomitant |
| Hypertension |
19.9% |
| Product Used For Unknown Indication |
16.7% |
| Drug Use For Unknown Indication |
14.2% |
| Pain |
7.7% |
| Diabetes Mellitus |
4.2% |
| Hormone Replacement Therapy |
4.0% |
| Rheumatoid Arthritis |
3.5% |
| Depression |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Osteoporosis |
2.8% |
| Arthralgia |
2.6% |
| Asthma |
2.6% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Nuclear Magnetic Resonance Imaging |
2.2% |
| Anxiety |
2.0% |
| Blood Cholesterol Increased |
1.8% |
| Coronary Artery Disease |
1.8% |
| Atrial Fibrillation |
1.7% |
| Blood Pressure |
1.7% |
| Coronary Artery Bypass |
1.7% |
|
| Vomiting |
14.0% |
| Urinary Tract Infection |
10.0% |
| Myocardial Infarction |
8.0% |
| Suicidal Ideation |
6.0% |
| Urine Abnormality |
6.0% |
| Weight Decreased |
6.0% |
| Pruritus |
5.0% |
| Breast Cancer Female |
4.0% |
| Oxygen Saturation Decreased |
4.0% |
| Skin Tightness |
4.0% |
| Unevaluable Event |
4.0% |
| Weight Increased |
4.0% |
| White Blood Cell Count Increased |
4.0% |
| Gastric Ulcer Haemorrhage |
3.0% |
| Haemoglobin Decreased |
3.0% |
| Headache |
3.0% |
| Hypertension |
3.0% |
| Nausea |
3.0% |
| Pleural Effusion |
3.0% |
| Rash |
3.0% |
|
